ASP2151 + Valacyclovir + Placebo
Phase 1Terminated 1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety of ASP2151
Conditions
Safety of ASP2151
Trial Timeline
Mar 1, 2009 → Apr 1, 2010
NCT ID
NCT00870441About ASP2151 + Valacyclovir + Placebo
ASP2151 + Valacyclovir + Placebo is a phase 1 stage product being developed by Astellas Pharma for Safety of ASP2151. The current trial status is terminated. This product is registered under clinical trial identifier NCT00870441. Target conditions include Safety of ASP2151.
What happened to similar drugs?
3 of 4 similar drugs in Safety of ASP2151 were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00870441 | Phase 1 | Terminated |
| NCT00486200 | Phase 2 | Completed |
Competing Products
20 competing products in Safety of ASP2151